GGrantIndex
← Leaderboards

Tihamer Orban

Joslin Diabetes Center

$2,699,845
Attributed
$2,699,845
Total exposure
17
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $725.5K · FY200508
$1M$750K$500K$250K$0
'05
'06
'07
'08

Funding mix

By agency

NIH$2,699,845 · 17

By mechanism

U01$2,218,606 · 1
M01$481,239 · 16

Top collaborators

No co-investigators on record.

Most similar at Joslin Diabetes Center

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsUnited States National Institutes Of HealthAutoantigensFundingResourcesInstitutionDiabetes Mellitus, Insulin-DependentResearch PersonnelInsulinSourceGrantInsulin Dependent Diabetes MellitusComputer Retrieval Of Information On Scientific Projects DatabasePatient Oriented ResearchHuman SubjectPreventDiabetes Mellitus TherapyHuman Therapy EvaluationFreund'S AdjuvantImmunoregulationDisease /Disorder Prevention /ControlAutoimmunityGenetic SusceptibilityImmunotherapy

Grant awards (25)

THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$6,402
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: NUTRITIONAL INTERVENTION TO PREVENT TYPE 1 DIABETES PILOT TRIAL$3,096
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: NEW ONSET OF TYPE 1 DIABETES MMF/DZB CLINICAL TRIAL$1,055
M01 · FY2008 · RR · contact PI
Type 1 Diabetes TrialNet: Clinical Centers$501,158
U01 · FY2007 · DK · contact PI
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$182,610
M01 · FY2007 · RR · contact PI
NEW ONSET OF TYPE 1 DIABETES MMF/DZB CLINICAL TRIAL$22,311
M01 · FY2007 · RR · contact PI
NUTRITIONAL INTERVENTION TO PREVENT TYPE 1 DIABETES PILOT TRIAL (NIP)$8,220
M01 · FY2007 · RR · contact PI
AUTOANTIGEN VACCINATION IN INDIVIDUALS WITH NEW ONSET TYPE 1 DIABETES MELLITUS$7,631
M01 · FY2007 · RR · contact PI
INSULIN RECEPTOR POSITIVE AND AUTOANTIGEN REACTIVE T CELLS IN TYPE 1 DIABETES$3,521
M01 · FY2007 · RR · contact PI
THE TRAILNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$72,393
M01 · FY2006 · RR · contact PI
AUTOANTIGEN VACCINATION IN INDIVIDUALS WITH NEW ONSET TYPE 1 DIABETES MELLITUS$13,071
M01 · FY2006 · RR · contact PI
NEW ONSET OF TYPE 1 DIABETES MMF/DZB CLINICAL TRIAL$5,530
M01 · FY2006 · RR · contact PI
INSULIN RECEPTOR POSITIVE AND AUTOANITGEN REACTIVE T CELLS IN TYPE 1 DIABETES$3,016
M01 · FY2006 · RR · contact PI
Type 1 Diabetes TrialNet: Clinical Centers$1
U01 · FY2006 · DK · contact PI
Type 1 Diabetes TrialNet: Clinical Centers$378,084
U01 · FY2005 · DK
THE TRAILNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$92,835
M01 · FY2005 · RR
AUTOANTIGEN VACCINATION IN INDIVIDUALS WITH NEW ONSET TYPE 1 DIABETES MELLITUS$47,328
M01 · FY2005 · RR
INSULIN RECEPTOR POSITIVE AND AUTOANTIGEN REACTIVE T CELLS IN TYPE 1 DIABETES$455
M01 · FY2005 · RR
Type 1 Diabetes TrialNet: Clinical Centers$349,446
U01 · FY2004 · DK
Autoimmune Vaccination in Individuals with New Onset Type 1 Diabetes Mellitus$10,356
M01 · FY2004 · RR
Insulin Receptor Positive and Autoantigen Reactive T Cells in Type 1 Diabetes$1,036
M01 · FY2004 · RR
Autoantigen Vaccin. in Individuals w/New Onset type I Diabetes Mellitus$373
M01 · FY2004 · RR
Type 1 Diabetes TrialNet: Clinical Centers$329,816
U01 · FY2003 · DK
Type 1 Diabetes TrialNet: Clinical Centers$344,758
U01 · FY2002 · DK
Type 1 Diabetes TrialNet: Clinical Centers$315,343
U01 · FY2001 · DK